What is Long COVID?
Most people who contract COVID-19 recover completely within a few weeks. But some people - even those who weren’t very sick in the first place - continue to experience lingering health problems several months after their initial recovery. These people are referred to as “long-haulers” and the condition is commonly referred to as “Long COVID.” Common long-lasting COVID symptoms include:
People of all ages and previous levels of health and fitness can develop Long COVID. In fact, it is estimated that approximately 30% of people who have COVID-19 get Long COVID. While the exact cause of Long COVID is unknown, doctors and researchers are studying new ways to potentially reduce Long COVID symptoms and improve quality of life.
About the Study
Right now, doctors at select locations throughout the U.S. are conducting a new phase 2 clinical study for people with Long COVID. The study is for an investigational drug that may help improve Long COVID symptoms when taken once nightly at bedtime for 14 weeks.
Who can participate? Adults 18 - 65 years old who are experiencing lingering COVID symptoms for more than 3 months after their initial infection.
Where? The study will enroll up to 470 adults at approximately 30 study locations throughout the U.S.
When? Now - the study is actively enrolling new participants.
How long does the study last? If you join the study, your participation will last about 6 months. During this time, you will be asked to meet with your local study doctor up to 6 times (about once a month) to provide feedback about your experiences. You will also have two telephone follow-up visits after you complete the study treatment. You will be compensated for your time and travel to attend these visits.
Has the study drug been tested on humans before? Yes. Several Phase 3 studies have been conducted with this study drug.
Will I have to pay for anything if I join the study? No, if you qualify and choose to join the study, you will receive all study-related care at no cost to you. This includes the study drug, as well as any visits to your study doctor’s office. Health insurance is NOT required to participate.
See If You Qualify
If you are 18 - 65 years old and are experiencing lingering COVID symptoms more than 3 months after your initial infection, you may be eligible to participate in a new clinical research study. The study is for an investigational drug that may help improve long COVID symptoms when taken once nightly at bedtime for 14 weeks. To see if you might qualify, and to connect with a local study center to learn more, please take the questionnaire below.